277 related articles for article (PubMed ID: 25825493)
1. Action at a distance: mutations of peripheral residues transform rapid reversible inhibitors to slow, tight binders of cyclooxygenase-2.
Blobaum AL; Xu S; Rowlinson SW; Duggan KC; Banerjee S; Kudalkar SN; Birmingham WR; Ghebreselasie K; Marnett LJ
J Biol Chem; 2015 May; 290(20):12793-803. PubMed ID: 25825493
[TBL] [Abstract][Full Text] [Related]
2. Molecular determinants for the selective inhibition of cyclooxygenase-2 by lumiracoxib.
Blobaum AL; Marnett LJ
J Biol Chem; 2007 Jun; 282(22):16379-90. PubMed ID: 17434872
[TBL] [Abstract][Full Text] [Related]
3. Fluorescent indomethacin-dansyl conjugates utilize the membrane-binding domain of cyclooxygenase-2 to block the opening to the active site.
Xu S; Uddin MJ; Banerjee S; Duggan K; Musee J; Kiefer JR; Ghebreselasie K; Rouzer CA; Marnett LJ
J Biol Chem; 2019 May; 294(22):8690-8698. PubMed ID: 31000626
[TBL] [Abstract][Full Text] [Related]
4. Fatty Acid Binding to the Allosteric Subunit of Cyclooxygenase-2 Relieves a Tonic Inhibition of the Catalytic Subunit.
Dong L; Yuan C; Orlando BJ; Malkowski MG; Smith WL
J Biol Chem; 2016 Dec; 291(49):25641-25655. PubMed ID: 27756840
[TBL] [Abstract][Full Text] [Related]
5. Substrate-selective Inhibition of Cyclooxygeanse-2 by Fenamic Acid Derivatives Is Dependent on Peroxide Tone.
Orlando BJ; Malkowski MG
J Biol Chem; 2016 Jul; 291(29):15069-81. PubMed ID: 27226593
[TBL] [Abstract][Full Text] [Related]
6. Conservative Secondary Shell Substitution In Cyclooxygenase-2 Reduces Inhibition by Indomethacin Amides and Esters via Altered Enzyme Dynamics.
Konkle ME; Blobaum AL; Moth CW; Prusakiewicz JJ; Xu S; Ghebreselasie K; Akingbade D; Jacobs AT; Rouzer CA; Lybrand TP; Marnett LJ
Biochemistry; 2016 Jan; 55(2):348-59. PubMed ID: 26704937
[TBL] [Abstract][Full Text] [Related]
7. Differential sensitivity and mechanism of inhibition of COX-2 oxygenation of arachidonic acid and 2-arachidonoylglycerol by ibuprofen and mefenamic acid.
Prusakiewicz JJ; Duggan KC; Rouzer CA; Marnett LJ
Biochemistry; 2009 Aug; 48(31):7353-5. PubMed ID: 19603831
[TBL] [Abstract][Full Text] [Related]
8. The structure of NS-398 bound to cyclooxygenase-2.
Vecchio AJ; Malkowski MG
J Struct Biol; 2011 Nov; 176(2):254-8. PubMed ID: 21843643
[TBL] [Abstract][Full Text] [Related]
9. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
Riendeau D; Percival MD; Boyce S; Brideau C; Charleson S; Cromlish W; Ethier D; Evans J; Falgueyret JP; Ford-Hutchinson AW; Gordon R; Greig G; Gresser M; Guay J; Kargman S; Léger S; Mancini JA; O'Neill G; Ouellet M; Rodger IW; Thérien M; Wang Z; Webb JK; Wong E; Chan CC
Br J Pharmacol; 1997 May; 121(1):105-17. PubMed ID: 9146894
[TBL] [Abstract][Full Text] [Related]
10. Isoform-selective interaction of cyclooxygenase-2 with indomethacin amides studied by real-time fluorescence, inhibition kinetics, and site-directed mutagenesis.
Timofeevski SL; Prusakiewicz JJ; Rouzer CA; Marnett LJ
Biochemistry; 2002 Jul; 41(30):9654-62. PubMed ID: 12135387
[TBL] [Abstract][Full Text] [Related]
11. Exploring the molecular determinants of substrate-selective inhibition of cyclooxygenase-2 by lumiracoxib.
Windsor MA; Valk PL; Xu S; Banerjee S; Marnett LJ
Bioorg Med Chem Lett; 2013 Nov; 23(21):5860-4. PubMed ID: 24060487
[TBL] [Abstract][Full Text] [Related]
12. The interaction of arginine 106 of human prostaglandin G/H synthase-2 with inhibitors is not a universal component of inhibition mediated by nonsteroidal anti-inflammatory drugs.
Greig GM; Francis DA; Falgueyret JP; Ouellet M; Percival MD; Roy P; Bayly C; Mancini JA; O'Neill GP
Mol Pharmacol; 1997 Nov; 52(5):829-38. PubMed ID: 9351974
[TBL] [Abstract][Full Text] [Related]
13. Human cyclooxygenase-2 is a sequence homodimer that functions as a conformational heterodimer.
Dong L; Vecchio AJ; Sharma NP; Jurban BJ; Malkowski MG; Smith WL
J Biol Chem; 2011 May; 286(21):19035-46. PubMed ID: 21467029
[TBL] [Abstract][Full Text] [Related]
14. Fluorescence quenching analysis of the association and dissociation of a diarylheterocycle to cyclooxygenase-1 and cyclooxygenase-2: dynamic basis of cyclooxygenase-2 selectivity.
Lanzo CA; Sutin J; Rowlinson S; Talley J; Marnett LJ
Biochemistry; 2000 May; 39(20):6228-34. PubMed ID: 10821698
[TBL] [Abstract][Full Text] [Related]
15. Arg-513 and Leu-531 Are Key Residues Governing Time-Dependent Inhibition of Cyclooxygenase-2 by Aspirin and Celebrex.
Dong L; Anderson AJ; Malkowski MG
Biochemistry; 2019 Sep; 58(38):3990-4002. PubMed ID: 31469551
[TBL] [Abstract][Full Text] [Related]
16. The structural basis of endocannabinoid oxygenation by cyclooxygenase-2.
Vecchio AJ; Malkowski MG
J Biol Chem; 2011 Jun; 286(23):20736-45. PubMed ID: 21489986
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents.
Kurumbail RG; Stevens AM; Gierse JK; McDonald JJ; Stegeman RA; Pak JY; Gildehaus D; Miyashiro JM; Penning TD; Seibert K; Isakson PC; Stallings WC
Nature; 1996 Dec 19-26; 384(6610):644-8. PubMed ID: 8967954
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of new 2,3-diarylquinoline derivatives as selective cyclooxygenase-2 inhibitors.
Ghodsi R; Zarghi A; Daraei B; Hedayati M
Bioorg Med Chem; 2010 Feb; 18(3):1029-33. PubMed ID: 20061161
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cyclooxygenase-1 crystal structures: cross-talk between monomers comprising cyclooxygenase-1 homodimers.
Sidhu RS; Lee JY; Yuan C; Smith WL
Biochemistry; 2010 Aug; 49(33):7069-79. PubMed ID: 20669977
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of ketoprofen analogs as potent cyclooxygenase-2 inhibitors.
Zarghi A; Ghodsi R
Bioorg Med Chem; 2010 Aug; 18(16):5855-60. PubMed ID: 20650641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
